About Lenvatinib Mesylate (Form-C) API
Therapeutic CategoryAnti-Cancer/ Oncology-es

CAS Number
API Technology
High Potent
Dose Form
Oral Solid/Capsules
Dr Reddy's Development Status
Available
Available Regulatory Filing
USDMF, Brazil DMF, Canada DMF, Korea DMF